You just read:

Bayer Submits New Drug Application for Regorafenib for the Treatment of Gastrointestinal Stromal Tumors (GIST)

News provided by

Bayer HealthCare Pharmaceuticals Inc.

Aug 30, 2012, 10:16 ET